Meito Sangyo Kabushiki Kaisha

Susumu Sasaki

Kyoji Kito

Hideo Nagae

Masakatsu Hasegawa

Akihiro Mizutani

Shusaburo Hokukoku

Yoshio Ito

Kimio Hirose

Nahoko Tozawa

Keiko Yamada

Takao Ogawa

Yasuji Yamashita

Masahiro Ohgai

Hisato Yamada

Wolfgang Ebert

Mayk Kresse

Susanne Wagner

Shigeo Maruno

Fumio Kuzuya

Detlef Pfefferer

Rudiger Lawaczeck

Tsuneo Fukata

Yukari Hino

Taketoshi Komori

Hideki Miyaji

Hiromi Hanai

Akio Koide

Takamasa Hanaichi

Katsutoshi Murase

Hisaaki Uchida

Provided is a bacteriostatic composition for salmonellae containing, as the active ingredient, a fermented broth obtained by effecting fermentation with the use of a lactic acid bacteriium belonging to the genus Leuconostoc, Streptococcus or Streptobacterium in a sucrose-containing medium, or a preparation originating in the supernatant obtained by subjecting the fermented broth to fractional precipitation from a water-miscible organic solvent.

Bacteriostatic composition for salmonellae

Polysaccharide derivative/magnetic metal oxide composite

Water-soluble carboxypolysaccharide-magnetic iron oxide complex having a

Oxidized complex comprising water-soluble carboxypolysaccharide and

Composition comprising magnetic metal oxide ultrafine particles and

A pharmaceutical composition comprising an amount, effective for inhibiting platelet aggregation, of guanosine monophosphate represented by the following formula ##STR1## wherein one of X, Y and Z represents a H.sub.2 PO.sub.3 group and the remaining two of these represent a hydrogen atom, or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable diluent or carrier.

Pharmaceutical composition useful for inhibiting platelet aggregation

A method for obtaining fibrinogen or its constituent components, which comprises contacting a fibrinogen-containing composition with at least one aminocarboxylic acid of the formula

Method for separating fibrinogen and its constituent components

A pharmaceutical composition containing as its active ingredient a disaccharide derivative having a derivative group of the following formula (1) bonded to a carbon atom of a disaccharide: ##STR1## wherein Y is a member of the group consisting of NH and O; and when Y is NH, Z is a member of the class consisting of --O-- (disaccharide residue) and --O--, with the proviso that one of the two bonds is attached to the other carbon atom of the same disaccharide to which the formula (1) group is bonded, and when Y is O, Z is a member of the class consisting of --NH.sub.2 and --O--, with the proviso that one of the two bonds is attached to a carbon atom of a disaccharide different from that to which the formula (1) group is bonded. The disaccharide derivative can be prepared by reacting a disaccharide with an activating agent selected from the group consisting of the cyanogen halides, organic cyanic acid esters and halogenocarbonic acid alkyl esters. Said pharmaceutical composition is useful for treating hepatic diseases.

Disaccharide derivatives used in the treatment of hepatic diseases

Growing community of inventors

Nagoya, Japan

Kyoji Kito